The fading guardian: clinical relevance of TP53 null mutation in high-grade serous ovarian cancers.
Biatta CM, Paudice M, Greppi M, Parrella V, Parodi A, De Luca G, Cerruti GM, Mammoliti S, Caroti C, Menichini P, Fronza G, Pesce S, Marcenaro E, Vellone VG.
Biatta CM, et al.
Front Immunol. 2023 Aug 23;14:1221605. doi: 10.3389/fimmu.2023.1221605. eCollection 2023.
Front Immunol. 2023.
PMID: 37680633
Free PMC article.